The A-HIPI Prediction Model in Advanced Stage Hodgkin Lymphoma: Identification of Risk Groups and Creation of an Online Tool
Blood Adv
.
2025 Jan 8:bloodadvances.2024014689.
doi: 10.1182/bloodadvances.2024014689.
Online ahead of print.
Authors
Matthew J Maurer
1
,
Susan K Parsons
2
,
Jenica N Upshaw
2
,
Angie Mae Rodday
2
,
Raphael Mwangi
1
,
Sára Rossetti
3
,
Jonathan W Friedberg
4
,
Andrea Gallamini
5
,
Massimo Federico
6
,
Eliza A Hawkes
7
,
David Hodgson
8
,
Peter W M Johnson
9
,
Brian L Link
10
,
Eric Mou
10
,
Kerry J Savage
11
,
Pier Luigi Zinzani
12
,
Andrew M Evens
13
Affiliations
1
Mayo Clinic, Rochester, Minnesota, United States.
2
Tufts Medical Center, Boston, Massachusetts, United States.
3
Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
4
University of Rochester, Rochester, New York, United States.
5
Antoine Lacassagne Cancer Center, Nice Cedex 2, France.
6
University of Modena and Reggio Emilia, Modena, Italy.
7
Monash University, Australia.
8
Princess Margaret Hospital, Toronto, Canada.
9
University of Southampton, Southampton, United Kingdom.
10
University of Iowa, Iowa City, Iowa, United States.
11
BC Cancer, Centre for Lymphoid Cancer, Vancouver, Canada.
12
University of Bologna, Bologna, Italy.
13
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States.
PMID:
39778124
DOI:
10.1182/bloodadvances.2024014689
No abstract available